ÑÇÖÞ×ÔοÊÓƵ

Craig H. Selzman
( out of 75 reviews )

Craig H. Selzman, MD

Languages spoken: English, Spanish

  • Dr. Craig Selzman is the Dr. Russell M. Nelson and Dantzel W. Nelson Presidential Endowed Chair as well as Professor and Chief of the Division of Cardiothoracic Surgery at the ÑÇÖÞ×ÔοÊÓƵ of Utah who specializes in the care of patients requiring heart surgery. He earned his undergraduate degree at Amherst College and medical degree at Baylor College of Medicine. He received his General and Cardiothoracic Surgery training at the ÑÇÖÞ×ÔοÊÓƵ of Colorado and is Board-Certified in both fields. Dr. Selzman was on faculty at the ÑÇÖÞ×ÔοÊÓƵ of North Carolina before joining the faculty at ÑÇÖÞ×ÔοÊÓƵ of Utah in 2008.



    Clinically, Dr. Selzman is the Surgical Director of the Cardiac Mechanical Support and Heart Transplant program and serves as the Medical Director of the Transplant Service Line for the ÑÇÖÞ×ÔοÊÓƵ Hospital. In addition to his role in the advanced Heart Failure and artificial heart program, he specializes in complex valvular heart disease including reoperative heart surgery, adult congenital heart disease, and aortic root reconstruction. He is one of a few surgeons in the Mountain West with significant experience with minimally invasive heart surgery for a wide variety of disease, and, in particular, mitral valve repair.


    Dr. Selzman is heavily involved with clinical research related to advanced heart failure, transplantation, and ventricular assist devices. He also has an active basic science collaboration with many of our researchers here at the ÑÇÖÞ×ÔοÊÓƵ of Utah. Dr. Selzman is one of a handful of cardiothoracic surgeons that runs a laboratory funded by the National Institute of ÑÇÖÞ×ÔοÊÓƵ. His research focus is related to examining mechanisms of heart recovery.

    Specialties

    Board Certification

    American Board of Thoracic Surgery (Thoracic Surg)

    Patient Rating

    5.0 /5
    ( out of 75 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 31, 2024
    UH HOSPITALS AND CLINICS

    Amazing surgeon, amazing person.

    October 17, 2024
    UH HOSPITALS AND CLINICS

    El Doctor Selzman me atendio muy bien, escucho y respondio todas mis preguntas amablemente, excelente profesional, nos dio mucha confianza y primero Dios se que estoy en muy buenas manos para cuando tenga que operarme, Gracias a Dios y a todos ustedes por su gran servicio y cuidados al paciente.

    October 10, 2024
    UH HOSPITALS AND CLINICS

    Dr. Selzman is a very caring surgeon!

    September 27, 2024
    UH HOSPITALS AND CLINICS

    Dr Selzman and his staff are hands down the best. I would highly recommend them. I felt very comfortable knowing that the best of the best was working on me.

    September 26, 2024
    UH HOSPITALS AND CLINICS

    Dr. Selman is very friendly, was easy to talk with and explained things very clearly. He was a joy to work with and look forward to seeing him again.

    September 23, 2024
    UH HOSPITALS AND CLINICS

    Very caring Dr. I felt very lucky to have him perform my surgery.

    September 15, 2024
    UH HOSPITALS AND CLINICS

    What an amazing Doctor. Love ya

    September 05, 2024
    UH HOSPITALS AND CLINICS

    The best of the best!! I highly recommend Dr. Selzman for Cardiothoracic care. Great person and great talent.

    July 25, 2024
    UH HOSPITALS AND CLINICS

    he explained everything very well and told me exactly what we are going to do next.

    See More Patient Comments

  • Dr. Craig Selzman is the Dr. Russell M. Nelson and Dantzel W. Nelson Presidential Endowed Chair as well as Professor and Chief of the Division of Cardiothoracic Surgery at the ÑÇÖÞ×ÔοÊÓƵ of Utah who specializes in the care of patients requiring heart surgery. He earned his undergraduate degree at Amherst College and medical degree at Baylor College of Medicine. He received his General and Cardiothoracic Surgery training at the ÑÇÖÞ×ÔοÊÓƵ of Colorado and is Board-Certified in both fields. Dr. Selzman was on faculty at the ÑÇÖÞ×ÔοÊÓƵ of North Carolina before joining the faculty at ÑÇÖÞ×ÔοÊÓƵ of Utah in 2008.



    Clinically, Dr. Selzman is the Surgical Director of the Cardiac Mechanical Support and Heart Transplant program and serves as the Medical Director of the Transplant Service Line for the ÑÇÖÞ×ÔοÊÓƵ Hospital. In addition to his role in the advanced Heart Failure and artificial heart program, he specializes in complex valvular heart disease including reoperative heart surgery, adult congenital heart disease, and aortic root reconstruction. He is one of a few surgeons in the Mountain West with significant experience with minimally invasive heart surgery for a wide variety of disease, and, in particular, mitral valve repair.


    Dr. Selzman is heavily involved with clinical research related to advanced heart failure, transplantation, and ventricular assist devices. He also has an active basic science collaboration with many of our researchers here at the ÑÇÖÞ×ÔοÊÓƵ of Utah. Dr. Selzman is one of a handful of cardiothoracic surgeons that runs a laboratory funded by the National Institute of ÑÇÖÞ×ÔοÊÓƵ. His research focus is related to examining mechanisms of heart recovery.

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions Cardiothoracic Surgery
    Board Certification
    American Board of Thoracic Surgery (Thoracic Surg)

    Education history

    Residency Cardiothoracic Surgery - ÑÇÖÞ×ÔοÊÓƵ of Colorado at Denver and ÑÇÖÞ×ÔοÊÓƵ Sciences Center Resident
    Surgery - ÑÇÖÞ×ÔοÊÓƵ of Colorado at Denver and ÑÇÖÞ×ÔοÊÓƵ Sciences Center Resident
    Internship Surgery - ÑÇÖÞ×ÔοÊÓƵ of Colorado at Denver and ÑÇÖÞ×ÔοÊÓƵ Sciences Center Intern
    Medicine - Baylor College of Medicine M.D.
    Undergraduate Political Science - Amherst College B.A.

    Selected Publications

    Journal Article

    1. Gelhard S, OBrien L, Vincenti S, Smego DR, Hobbs R, Varghese TK Jr, Selzman CH, Pereira SJ (2023). Disparities in Gender and Diversity Representation Among Surgical Subspecialties: Are we Losing Momentum? J Surg Res, 293, 413-419. ()
    2. Kagawa H, Goodwin M, Stehlik J, Campsen J, Baker T, Selzman CH (2023). A Case Report of Triple Organ Transplantation From a Donor After Circulatory Death Using Thoraco-Abdominal Normothermic Regional Perfusion. Transplant Proc, 55(8), 1883-1887. ()
    3. Kagawa H, Stringham J, Selzman C, Goodwin M, Frye L, Raman S, Cahill B, Morrell M (2023). Case Report of Needle Disruption of the Retroperitoneal Lymph Nodes for Refractory Chylothorax After Double Lung Transplantation. Transplant Proc, 55(8), 1981-1983. ()
    4. Hirahara AM, Khan MS, Ishidoya Y, Smego D, Roman O, Ranjan R, Krueger L, Hoareau G, Selzman CH, Dosdall DJ (2023). Canine Model of Ischemia-Induced Ventricular Tachycardia. J Surg Res, 293, 196-203. ()
    5. Glotzbach JP, Hanson HA, Tonna JE, Horns JJ, Allen CM, Presson AP, Griffin CL, Zak M, Sharma V, Tristani-Firouzi M, Selzman CH (2023). Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database. Circulation, 148(8).
    6. Glotzbach JP, Hanson HA, Tonna JE, Horns JJ, McCarty Allen C, Presson AP, Griffin CL, Zak M, Sharma V, Tristani-Firouzi M, Selzman CH (2023). Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database. Circulation, 148(8), 637-647. ()
    7. Kyriakopoulos CP, Horne BD, Sideris K, Taleb I, Griffin RJ, Sheffield E, Alharethi R, Hanff TC, Stehlik J, Selzman CH, Drakos SG (2023). Left ventricular functional improvement appears to contribute to lower rates of device thrombosis in patients on durable mechanical circulatory support. J Heart Lung Transplant, 42(7), 853-858. ()
    8. Khan MS, Smego D, Ishidoya Y, Hirahara AM, Offei E, Ruiz Castillo MS, Gharbia O, Li H, Palatinus JA, Krueger L, Hong T, Hoareau GL, Ranjan R, Selzman CH, Shaw RM, Dosdall DJ (2023). A canine model of chronic ischemic heart failure. Am J Physiol Heart Circ Physiol, 324(6), H751-H761. ()
    9. Gatsiou A, Tual-Chalot S, Napoli M, Ortega-Gomez A, Regen T, Badolia R, Cesarini V, Garcia-Gonzalez C, Chevre R, Ciliberti G, Silvestre-Roig C, Martini M, Hoffmann J, Hamouche R, Visker JR, Diakos N, Wietelmann A, Silvestris DA, Georgiopoulos G, Moshfegh A, Schneider A, Chen W, Guenther S, Backs J, Kwak S, Selzman CH, Stamatelopoulos K, Rose-John S, Trautwein C, Spyridopoulos I, Braun T, Waisman A, Gallo A, Drakos SG, Dimmeler S, Sperandio M, Soehnlein O, Stellos K (2023). The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation. Immunity, 56(5), 979-997.e11. ()
    10. Hirahara AM, Khan MS, Gharbia OA, Lange M, Ishidoya Y, Smego D, Ranjan R, Stoddard GJ, Selzman CH, Dosdall DJ (2023). Antitachycardia pacing at the His bundle is safer than conventional right ventricular antitachycardia pacing in a canine myocardial ischemic injury model. J Cardiovasc Electrophysiol, 34(5), 1249-1256. ()
    11. Palatinus JA, Valdez S, Taylor L, Whisenant C, Selzman CH, Drakos SG, Ranjan R, Hong T, Saffitz JE, Shaw RM (2023). GJA1-20k Rescues Cx43 Localization and Arrhythmias in Arrhythmogenic Cardiomyopathy. Circ Res, 132(6), 744-746. ()
    12. Hanff TC, Browne A, Dickey J, Gaines H, Harhay MO, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik J (2022). Heart waitlist survival in adults with an intra-aortic balloon pump relative to other Status 2, Status 1, and inotrope Status 3 patients. J Heart Lung Transplant, 42(3), 368-376. ()
    13. Selzman CH, Feller ED, Walker JC, Sheridan BC, Silvestry SC, Daly RC, Anyanwu AC, Madigan D, Liu PY, Frazier OH, Jorde UP, Griffith BP (2022). The Jarvik 2000 Left Ventricular Assist Device: Results of the United States Bridge to Transplant Trial. ASAIO J, 69(2), 174-182. ()
    14. Browne A, Gaines H, Alharethi R, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik J, Hanff TC (2022). Interrupted Time Series Analysis of Donor Heart Use Before and After the 2018 UNOS Heart Allocation Policy Change. J Card Fail, 29(2), 220-224. ()
    15. Drakos SG, Badolia R, Makaju A, Kyriakopoulos CP, Wever-Pinzon O, Tracy CM, Bakhtina A, Bia R, Parnell T, Taleb I, Ramadurai DKA, Navankasattusas S, Dranow E, Hanff TC, Tseliou E, Shankar TS, Visker J, Hamouche R, Stauder EL, Caine WT, Alharethi R, Selzman CH, Franklin S (2022). Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation, 147(5), 409-424. ()
    16. Vigneshwar NG, Masood MF, Vasic I, Krause M, Bartels K, Lucas MT, Bronsert M, Selzman CH, Thompson S, Rove JY, Reece TB, Cleveland JC, Pal JD, Fullerton DA, Aftab M (2022). Venovenous extracorporeal membrane oxygenation support in patients with COVID-19 respiratory failure: A multicenter study. JTCVS Open, 12, 211-220. ()
    17. Ciullo AL, Wall N, Taleb I, Koliopoulou A, Stoddard K, Drakos SG, Welt FG, Goodwin M, Van Dyk N, Kagawa H, McKellar SH, Selzman CH, Tonna JE (2022). Effect of Portable, In-Hospital Extracorporeal Membrane Oxygenation on Clinical Outcomes. J Clin Med, 11(22). ()
    18. Wert L, Stewart GC, Mehra MR, Milwidsky A, Jorde UP, Goldstein DJ, Selzman CH, Stehlik J, Alshamdin FD, Khaliel FH, Gustafsson F, Boschi S, Loforte A, Ajello S, Scandroglio AM, Tuanov Z, Netuka I, Schlglhofer T, Zimpfer D, Zijderhand CF, Caliskan K, Dogan G, Schmitto JD, Maier S, Schibilsky D, Jawad K, Saeed D, Faerber G, Morshuis M, Hanuna M, Mller CS, Mulzer J, Kempfert J, Falk V, Potapov EV (2022). A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device. J Thorac Cardiovasc Surg. ()
    19. Felker GM, Buttrick P, Rosenzweig A, Abel ED, Allen LA, Bristow M, Das S, DeVore AD, Drakos SG, Fang JC, Freedman JE, Hernandez AF, Li DY, McKinsey TA, Newton-Cheh C, Rogers JG, Shah RV, Shah SH, Stehlik J, Selzman CH (2022). Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions. J Am Heart Assoc, 11(18), e025517. ()
    20. Tonna JE, Selzman CH, Bartos JA, Presson AP, Ou Z, Jo Y, Becker L, Youngquist ST, Thiagarajan RR, Johnson MA, Rycus P, Keenan HT (2022). The Association of Modifiable Postresuscitation Management and Annual Case Volume With Survival After Extracorporeal Cardiopulmonary Resuscitation. Crit Care Explor, 4(7), e0733. ()
    21. Sadeh B, Ugolini S, Pinzon OW, Potapov EV, Selzman CH, Bader F, Zuckermann AO, Gomez-Mesa JE, Shah KS, Alharethi R, Morejon-Barragan P, Hanff T, Goldraich LA, Farrero M, MacDonald PS, Drakos S, Mehra MR, Stehlik J (2022). Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: An international practice survey. Clin Transplant, 36(7), e14733. ()
    22. Orkild BA, Zenger B, Iyer K, Rupp LC, Ibrahim MM, Khashani AG, Perez MD, Foote MD, Bergquist JA, Morris AK, Kim JJ, Steinberg BA, Selzman C, Ratcliffe MB, MacLeod RS, Elhabian S, Morgan AE (2022). All Roads Lead to Rome: Diverse Etiologies of Tricuspid Regurgitation Create a Predictable Constellation of Right Ventricular Shape Changes. Front Physiol, 13, 908552. ()
    23. Kapelios CJ, Lund LH, Wever-Pinzon O, Selzman CH, Myers SL, Cantor RS, Stehlik J, Chamogeorgakis T, McKellar SH, Koliopoulou A, Alharethi R, Kfoury AG, Bonios M, Adamopoulos S, Gilbert EM, Fang JC, Kirklin JK, Drakos SG (2022). Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database. Circ Heart Fail, 15(6), e008706. ()
    24. Tonna JE, Selzman CH, Bartos JA, Presson AP, Ou Z, Jo Y, Becker LB, Youngquist ST, Thiagarajan RR, Austin Johnson M, Cho SM, Rycus P, Keenan HT (2022). The association of modifiable mechanical ventilation settings, blood gas changes and survival on extracorporeal membrane oxygenation for cardiac arrest. Resuscitation, 174, 53-61. ()
    25. Topkara VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, Takeda K, Takayama H, Selzman CH, Naka Y, Burkhoff D, Stehlik J, Farr MA, Fang JC, Uriel N, Drakos SG (2021). Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. J Am Coll Cardiol, 79(9), 900-913. ()
    26. Tonna JE, Selzman CH, Girotra S, Presson AP, Thiagarajan RR, Becker LB, Zhang C, Rycus P, Keenan HT, American Heart Association Get With the GuidelinesResuscitation Investigators (2022). Resuscitation Using ECPR During In-Hospital Cardiac Arrest (RESCUE-IHCA) Mortality Prediction Score and External Validation. JACC Cardiovasc Interv, 15(3), 237-247. ()
    27. Wilson TW, Horns JJ, Sharma V, Goodwin ML, Kagawa H, Pereira SJ, McKellar SH, Selzman CH, Glotzbach JP (2022). Minimally Invasive versus Full Sternotomy SAVR in the Era of TAVR: An Institutional Review. J Clin Med, 11(3). ()
    28. Sommakia S, Almaw NH, Lee SH, Ramadurai DKA, Taleb I, Kyriakopoulos CP, Stubben CJ, Ling J, Campbell RA, Alharethi RA, Caine WT, Navankasattusas S, Hoareau GL, Abraham AE, Fang JC, Selzman CH, Drakos SG, Chaudhuri D (2021). FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure. Circ Heart Fail, 15(3), CIRCHEARTFAILURE121008910. ()
    29. Diakos NA, Taleb I, Kyriakopoulos CP, Shah KS, Javan H, Richins TJ, Yin MY, Yen CG, Dranow E, Bonios MJ, Alharethi R, Koliopoulou AG, Taleb M, Fang JC, Selzman CH, Stellos K, Drakos SG (2021). Circulating and Myocardial Cytokines Predict Cardiac Structural and Functional Improvement in Patients With Heart Failure Undergoing Mechanical Circulatory Support. J Am Heart Assoc, 10(20), e020238. ()
    30. Khan MS, Lange M, Ranjan R, Sharma V, Glotzbach JP, Selzman C, Dosdall DJ (2021). Premature atrial stimulation accentuates conduction abnormalities in cardiac surgery patients that develop postoperative atrial fibrillation. J Electrocardiol, 69, 36-43. ()
    31. Javan H, Li L, Schaaf CL, Lee YS, Salama ME, Dinarello CA, Selzman CH (2021). Interleukin 1 receptor antagonism abrogates acute pressure-overload induced murine heart failure. Ann Thorac Surg. ()
    32. Healy AH, Bowen M, McKellar SH, Koliopoulou A, Drakos SG, Selzman CH (2021). Interleukin-1 Receptor Antagonism as Adjunct Therapy for Heart Failure Patients with Left Ventricular Assist Devices. ASAIO J, 67(8), e145-e147. ()
    33. Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik J (2022). Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol, 6(8), 957-962. ()
    34. Lyu Y, Verma VK, Lee Y, Taleb I, Badolia R, Shankar TS, Kyriakopoulos CP, Selzman CH, Caine W, Alharethi R, Navankasattusas S, Seidel T, Drakos SG, Sachse FB (2021). Remodeling of t-system and proteins underlying excitation-contraction coupling in aging versus failing human heart. NPJ Aging Mech Dis, 7(1), 16. ()
    35. Carley AN, Maurya SK, Fasano M, Wang Y, Selzman CH, Drakos SG, Lewandowski ED (2021). Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart. Circulation, 143(18), 1797-1808. ()
    36. Shah P, Psotka M, Taleb I, Alharethi R, Shams MA, Wever-Pinzon O, Yin M, Latta F, Stehlik J, Fang JC, Diao G, Singh R, Ijaz N, Kyriakopoulos CP, Zhu W, May CW, Cooper LB, Desai SS, Selzman CH, Kfoury AG, Drakos SG (2021). Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages. Circ Heart Fail, 14(5), e007991. ()
    37. Hydren JR, Gifford JR, Jarrett CL, Park SH, Shields KL, Broxterman RM, Kithas AC, Bisconti AV, Thurston TS, Ratchford SM, Wray DW, Stehlik J, Selzman CH, Drakos SG, Richardson RS (2021). Vascular function in continuous-flow left ventricular assist device recipients: effect of a single pulsatility treatment session. Am J Physiol Regul Integr Comp Physiol, 320(4), R425-R437. ()
    38. Tonna JE, Pierce J, Hatton N, Lewis G, Phillips JD, Messina A, Skidmore CR, Taylor K, Selzman CH (2021). Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial. BMJ Open, 11(2), e045162. ()
    39. Selzman CH, Tonna JE, Pierce J, Vargas C, Skidmore C, Lewis G, Hatton ND, Phillips JD (2021). A pilot trial of human amniotic fluid for the treatment of COVID-19. BMC Res Notes, 14(1), 32. ()
    40. Hoffman M, Palioura D, Kyriazis ID, Cimini M, Badolia R, Rajan S, Gao E, Nikolaidis N, Schulze PC, Goldberg IJ, Kishore R, Yang VW, Bannister TD, Bialkowska AB, Selzman CH, Drakos SG, Drosatos K (2021). Cardiomyocyte Krüppel-like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy. Circulation, 143(11), 1139-1156. ()
    41. Sharma V, Glotzbach JP, Ryan J, Selzman CH (2021). Evaluating Quality in Adult Cardiac Surgery. Tex Heart Inst J, 48(1). ()
    42. Moore B, Morgan N, Selzman C, Zimmerman J (2020). Successful Use of Limited Transthoracic Echocardiography to Guide Veno-venous Extracorporeal Membrane Oxygenator Placement in a Patient With Coronavirus Disease 2019. J Cardiothorac Vasc Anesth, 34(12), 3491-3493. ()
    43. Birks EJ, Drakos SG, Patel SR, Lowes BD, Selzman CH, Starling RC, Trivedi J, Slaughter MS, Alturi P, Goldstein D, Maybaum S, Um JY, Margulies KB, Stehlik J, Cunningham C, Farrar DJ, Rame JE (2020). Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results. Circulation, 142(21), 2016-2028. ()
    44. Frey C, Koliopoulou AG, Montenont E, Tolley ND, Javan H, McKellar SH, Drakos SG, Selzman CH, Rondina MT (2020). Longitudinal assessment of the platelet transcriptome in advanced heart failure patients following mechanical unloading. Platelets, 31(7), 952-959. ()
    45. Sharma V, DeShazo RA, Skidmore CR, Glotzbach JP, Koliopoulou A, Javan H, McKellar SH, Powell DL, Selzman CH (2019). Surgical explantation of atrial septal closure devices for refractory nickel allergy symptoms. J Thorac Cardiovasc Surg, 160(2), 502-509.e1. ()
    46. Taleb I, Wever-Pinzon J, Wang W, Koliopoulou A, Dranow E, Yu T, Yin L, McKellar SH, Stehlik J, Fang JC, Wever-Pinzon O, Selzman CH, Drakos SG (2019). Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis. Heart Lung Circ, 29(8), 1226-1233. ()
    47. Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, Krokidi AT, Navankasattusas S, McKellar SH, Yin M, Kfoury AG, Wever-Pinzon O, Fang JC, Selzman CH, Chaudhuri D, Rutter J, Drakos SG (2020). The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure. Circulation, 142(3), 259-274. ()
    48. Khan MS, Yamashita K, Sharma V, Ranjan R, Selzman CH, Dosdall DJ (2019). Perioperative Biomarkers Predicting Postoperative Atrial Fibrillation Risk After Coronary Artery Bypass Grafting: A Narrative Review. J Cardiothorac Vasc Anesth, 34(7), 1933-1941. ()
    49. Tonna JE, Selzman CH, Girotra S, Presson AP, Thiagarajan RR, Becker LB, Zhang C, Keenan HT, American Heart Associations Get With the GuidelinesResuscitation Investigators (2020). Patient and Institutional Characteristics Influence the Decision to Use Extracorporeal Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest. J Am Heart Assoc, 9(9), e015522. ()
    50. Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O (2019). Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC Heart Fail, 8(4), 302-312. ()
    51. Tonna JE, McKellar SH, Selzman CH, Drakos S, Koliopoulou AG, Taleb I, Stoddard GJ, Stehlik J, Welt FGP, Fair JF 3rd, Stoddard K, Youngquist ST (2020). Exploratory analysis of myocardial function after extracorporeal cardiopulmonary resuscitation vs conventional cardiopulmonary resuscitation. BMC Res Notes, 13(1), 137. ()
    52. Hydren JR, Kithas AC, Park SH, Wever-Pinzon O, Selzman CH, Perry W, Vargas CAS, Stehlik J, Drakos SG, Richardson RS (2019). Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed. ASAIO J, 66(3), 291-299. ()
    53. Kirklin JK, Pagani FD, Goldstein DJ, John R, Rogers JG, Atluri P, Arabia FA, Cheung A, Holman W, Hoopes C, Jeevanandam V, John R, Jorde UP, Milano CA, Moazami N, Naka Y, Netuka I, Pagani FD, Pamboukian SV, Pinney S, Rogers JG, Selzman CH, Silverstry S, Slaughter M, Stulak J, Teuteberg J, Vierecke J, Schueler S, DAlessandro DA (2020). American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. J Thorac Cardiovasc Surg, 159(3), 865-896. ()
    54. Editors, Kirklin JK, Pagani FD, Goldstein DJ, John R, Rogers JG, Contributing Authors, Atluri P, Arabia FA, Cheung A, Holman W, Hoopes C, Jeevanandam V, John R, Jorde UP, Milano CA, Moazami N, Naka Y, Netuka I, Pagani FD, Pamboukian SV, Pinney S, Rogers JG, Selzman CH, Silverstry S, Slaughter M, Stulak J, Teuteberg J, Vierecke J, Reviewers, Schueler S, DAlessandro DA (2020). American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. J Heart Lung Transplant, 39(3), 187-219. ()
    55. Wohlfahrt P, Zickmund SL, Slager S, Allen LA, Nicolau JN, Kfoury AG, Felker GM, Conte J, Flint K, DeVore AD, Selzman CH, Hess R, Spertus JA, Stehlik J (2020). Provider Perspectives on the Feasibility and Utility of Routine Patient-Reported Outcomes Assessment in Heart Failure: A Qualitative Analysis. J Am Heart Assoc, 9(2), e013047. ()
    56. Bowen ME, Selzman CH, McKellar SH (2019). Right Ventricular Involution: Big Changes in Small Hearts. J Surg Res, 243, 255-264. ()
    57. Pepin ME, Drakos S, Ha CM, Tristani-Firouzi M, Selzman CH, Fang JC, Wende AR, Wever-Pinzon O (2019). DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure. Am J Physiol Heart Circ Physiol, 317(4), H674-H684. ()
    58. Pires KM, Torres NS, Buffolo M, Gunville R, Schaaf C, Davis K, Selzman CH, Gottlieb RA, Boudina S (2019). Suppression of Cardiac Autophagy by Hyperinsulinemia in Insulin Receptor-Deficient Hearts Is Mediated by Insulin-Like Growth Factor Receptor Signaling. Antioxid Redox Signal, 31(6), 444-457. ()
    59. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J (2019). Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant, 38(8), 858-869. ()
    60. Symons JD, Deeter L, Deeter N, Bonn T, Cho JM, Ferrin P, McCreath L, Diakos NA, Taleb I, Alharethi R, McKellar S, Wever-Pinzon O, Navankasattusas S, Selzman CH, Fang JC, Drakos SG (2019). Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy. Circ Heart Fail, 12(8), e006085. ()
    61. DeBoard ZM, Varghese TK Jr, Doty JR, Selzman CH (2019). Cardiothoracic Surgery Residency Training in Surgical Ablation for Atrial Fibrillation. J Atr Fibrillation, 12(1), 2195. ()
    62. Cahill BC, Raman S, Stringham JR, McKellar SH, Selzman CH, Liou TG (2018). Longer Life or More Life: Choose One Please. J Surg Res, 237, 126-128. ()
    63. Uriel N, Burkhoff D, Rich JD, Drakos SG, Teuteberg JJ, Imamura T, Rodgers D, Raikhelkar J, Vorovich EE, Selzman CH, Kim G, Sayer G (2019). Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes. Circ Heart Fail, 12(4), e006067. ()
    64. Yau TM, Pagani FD, Mancini DM, Chang HL, Lala A, Woo YJ, Acker MA, Selzman CH, Soltesz EG, Kern JA, Maltais S, Charbonneau E, Pan S, Marks ME, Moquete EG, OSullivan KL, Taddei-Peters WC, McGowan LK, Green C, Rose EA, Jeffries N, Parides MK, Weisel RD, Miller MA, Hung J, OGara PT, Moskowitz AJ, Gelijns AC, Bagiella E, Milano CA, Cardiothoracic Surgical Trials Network (2019). Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial. JAMA, 321(12), 1176-1186. ()
    65. Yamashita K, Hu N, Ranjan R, Selzman CH, Dosdall DJ (2018). Clinical Risk Factors for Postoperative Atrial Fibrillation among Patients after Cardiac Surgery. Thorac Cardiovasc Surg, 67(2), 107-116. ()
    66. Hickman AW, Lonardo NW, Mone MC, Presson AP, Zhang C, Barton RG, Selzman CH, Drakos SG, Koliopoulou A, McKellar SH (2018). Acid Suppression to Prevent Gastrointestinal Bleeding in Patients With Ventricular Assist Devices. J Surg Res, 234, 96-102. ()
    67. Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, Nativi-Nicolau J, Stehlik J, Reid BB, Koliopoulou A, Stoddard GJ, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O (2018). Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support. Circ Heart Fail, 11(11), e005267. ()
    68. Silverton NA, Patel R, Zimmerman J, Ma J, Stoddard G, Selzman CH, Morrissey CK (2018). Intraoperative Transesophageal Echocardiography and Right Ventricular Failure After Left Ventricular Assist Device Implantation. J Cardiothorac Vasc Anesth, 32(5), 2096-2103. ()
    69. Glotzbach JP, Sharma V, Tonna JE, Pettit JC, McKellar SH, Eckhauser AW, Varghese TK Jr, Selzman CH (2018). Value-driven cardiac surgery: Achieving "perfect care" after coronary artery bypass grafting. J Thorac Cardiovasc Surg, 156(4), 1436-1448.e2. ()
    70. McKellar SH, Koliopoulou A, Selzman CH (2018). Atrial Fibrillation in Advanced Heart Failure Patients Receiving Left Ventricular Assist Devices. ASAIO J, 64(5), 573-574. ()
    71. Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, Nahrendorf M, Epelman S, Kreisel D, Liu Y, Itoh A, Shankar TS, Selzman CH, Drakos SG, Lavine KJ (2018). The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med, 24(8), 1234-1245. ()
    72. Daud A, Xu D, Revelo MP, Shah Z, Drakos SG, Dranow E, Stoddard G, Kfoury AG, Hammond MEH, Nativi-Nicolau J, Alharethi R, Miller DV, Gilbert EM, Wever-Pinzon O, McKellar SH, Afshar K, Khan F, Fang JC, Selzman CH, Stehlik J (2018). Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy. Circ Heart Fail, 11(8), e004759. ()
    73. Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos SG (2017). Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study. Circ Cardiovasc Imaging, 11(4), e007117. ()
    74. Zuiga Cisneros J, Stehlik J, Selzman CH, Drakos SG, McKellar SH, Wever-Pinzon O (2017). Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation. Circ Heart Fail, 11(3), e004378. ()
    75. Wozniak CJ, Stehlik J, Baird BC, McKellar SH, Song HK, Drakos SG, Selzman CH (2014). Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing database. Ann Thorac Surg, 97(4), 1364-71; discussion 1371-2. ()
    76. Carson P, Wertheimer J, Miller A, OConnor CM, Pina IL, Selzman C, Sueta C, She L, Greene D, Lee KL, Jones RH, Velazquez EJ (2013). Surgical Treatment for Ischemic Heart Failure (STICH) Trial: Mode of Death Results.LID - 10.1016/j.jchf.2013.04.012 [doi]. JACC Heart Fail, 1(5). ()
    77. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH (2013). Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg, 95(3), 870-5. ()
    78. Stanfield JR, Selzman CH (2013). In vitro pulsatility analysis of axial-flow and centrifugal-flow left ventricular assist devices. J Biomech Eng, 135(3), 34505. ()
    79. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation, 127(4), 452-62. ()
    80. Selzman CH (2012). Invited commentary. Ann Thorac Surg, 94(6), 2024. ()
    81. Andersen NM, Stansfield WE, Tang RH, Rojas M, Patterson C, Selzman CH (2012). Recovery from decompensated heart failure is associated with a distinct, phase-dependent gene expression profile. J Surg Res, 178(1), 72-80. ()
    82. Andersen NM, Tang R, Li L, Javan H, Zhang XQ, Selzman CH (2012). Inhibitory kappa-B kinase-β inhibition prevents adaptive left ventricular hypertrophy. J Surg Res, 178(1), 105-9. ()
    83. Stanfield JR, Selzman CH, Pardyjak ER, Bamberg S (2012). Flow characteristics of continuous-flow left ventricular assist devices in a novel open-loop system. ASAIO J, 58(6), 590-6. ()
    84. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li DY (2012). Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation, 126(2), 230-41. ()
    85. Wozniak CJ, Baird BC, Stehlik J, Drakos SG, Bull DA, Patel AN, Selzman CH (2012). Improved survival in heart transplant patients living at high altitude. J Thorac Cardiovasc Surg, 143(3), 735-741.e1. ()
    86. Selzman CH, Desjardins G, Patel AN, Davis E, Dick S, Stehlik J (2012). Complications associated with the use of left ventricular assist device therapy in an adult patient with Ebstein's anomaly. Ann Thorac Surg, 93(1), 297-9.
    87. Selzman CH, Desjardins G, Patel AN, Davis E, Dick S, Stehlik J (2010). Complications associated with the use of left ventricular assist device therapy in an adult patient with Ebstein's anomaly. Ann Thorac Surg, 93(1), 297-9. ()
    88. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME (2012). A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant, 31(1), 46-51. ()
    89. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 11(12), 2755-61. ()
    90. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman CH (2011). Allograft rejection in patients supported with continuous-flow left ventricular assist devices. Ann Thorac Surg, 92(5), 1601-7; discussion 1607. ()
    91. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J (2011). Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 30(8), 854-61. ()
    92. Selzman CH (2011). Invited commentary. Ann Thorac Surg, 92(1), 153-4. ()
    93. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik J (2011). Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol, 26(3), 245-55. ()
    94. Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury AG (2011). Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? J Heart Lung Transplant, 30(2), 144-50. ()
    95. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY (2010). Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol, 56(5), 382-91. ()
    96. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN (2010). The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. J Thorac Cardiovasc Surg, 140(1), 169-73. ()
    97. Selzman C (2010). Invited commentary. Ann Thorac Surg, 90(1), 123. ()
    98. Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund D, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher P, Bull DA, Selzman C, Stehlik J (2010). Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant, 29(3), 235-9. ()
    99. Raymond AL, Kfoury AG, Bishop CJ, Davis ES, Goebel KM, Stoker S, Selzman CH, Clayson SE, Smith H, Cowley CG, Alharethi R, Budge D, Reid BB (2010). Obesity and left ventricular assist device driveline exit site infection. ASAIO J, 56(1), 57-60. ()
    100. Stansfield WE, Andersen NM, Tang RH, Selzman CH (2009). Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart. Ann Thorac Surg, 88(6), 1916-21. ()
    101. Campbell RA, Overmyer KA, Selzman CH, Sheridan BC, Wolberg AS (2009). Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood, 114(23), 4886-96. ()
    102. Kouretas PC, Kaza AK, Burch PT, Witte MK, Clayson SE, Everitt MD, Selzman CH (2009). Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recovery. Artif Organs, 33(11), 1002-4. ()
    103. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang DZ (2009). MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest, 119(9), 2772-86. ()
    104. Drakos SG, Kfoury AG, Kotter JR, Reid BB, Clayson SE, Selzman CH, Stehlik J, Fisher PW, Merida M 3rd, Eckels DD, Brunisholz K, Horne BD, Stoker S, Li DY, Renlund DG (2009). Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant, 28(8), 838-42. ()
    105. Selzman C (2009). Invited commentary. Ann Thorac Surg, 88(1), 53. ()
    106. Kouretas PC, Kaza AK, Burch PT, Witte MK, Clayson SE, Everitt MD, Selzman CH (2009). Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recovery. Artif Organs, 33(11), 1002-4.
    107. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, OConnor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL, STICH Hypothesis 2 Investigators (2009). Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med, 360(17), 1705-17.
    108. Willis MS, Rojas M, Li L, Selzman CH, Tang RH, Stansfield WE, Rodriguez JE, Glass DJ, Patterson C (2009). Muscle ring finger 1 mediates cardiac atrophy in vivo. Am J Physiol Heart Circ Physiol, 296(4), H997-H1006. ()
    109. Selzman C (2008). Invited commentary. Ann Thorac Surg, 87(3), 819. ()
    110. Stansfield WE, Charles PC, Tang RH, Rojas M, Bhati R, Moss NC, Patterson C, Selzman CH (2009). Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile. J Thorac Cardiovasc Surg, 137(1), 232-8, 238e1-8. ()
    111. Moss NC, Tang RH, Willis M, Stansfield WE, Baldwin AS, Selzman CH (2008). Inhibitory kappa B kinase-beta is a target for specific nuclear factor kappa B-mediated delayed cardioprotection. J Thorac Cardiovasc Surg, 136(5), 1274-9. ()
    112. Tang RH, Zheng XL, Callis TE, Stansfield WE, He J, Baldwin AS, Wang DZ, Selzman CH (2008). Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression. Proc Natl Acad Sci U S A, 105(9), 3362-7. ()
    113. Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G, Patterson C, Hannon GJ, Wang DZ (2008). Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A, 105(6), 2111-6. ()
    114. Selzman CH (2008). Invited commentary. Ann Thorac Surg, 85(2), 585-6. ()
    115. Stansfield WE, Tang RH, Moss NC, Baldwin AS, Willis MS, Selzman CH (2008). Proteasome inhibition promotes regression of left ventricular hypertrophy. Am J Physiol Heart Circ Physiol, 294(2), H645-50. ()
    116. Riesenman PJ, Farber MA, Mauro MA, Selzman CH, Feins RH (2007). Aortoesophageal fistula after thoracic endovascular aortic repair and transthoracic embolization. J Vasc Surg, 46(4), 789-91. ()
    117. Moss NC, Stansfield WE, Willis MS, Tang RH, Selzman CH (2007). IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol, 293(4), H2248-53. ()
    118. Stansfield WE, Rojas M, Corn D, Willis M, Patterson C, Smyth SS, Selzman CH (2007). Characterization of a model to independently study regression of ventricular hypertrophy. J Surg Res, 142(2), 387-93. ()
    119. Selzman CH, Chang PP, Vernon-Platt T, Bowen A, Kowalczyk S, Sheridan BC (2007). Use of the Jarvik 2000 continuous flow left ventricular assist device for acute myocardial infarction and cardiogenic shock. J Heart Lung Transplant, 26(7), 756-8. ()
    120. Selzman CH, Sheridan BC (2007). Off-pump insertion of continuous flow left ventricular assist devices. J Card Surg, 22(4), 320-2. ()
    121. Stansfield WE, Moss NC, Willis MS, Tang R, Selzman CH (2007). Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. Ann Thorac Surg, 84(1), 120-5. ()
    122. Selzman CH, Chang PP, Vernon-Platt T, Bowen A, Kowalczyk S, Sherican BC (2007). Use of the Jarvik 2000 continous flow left ventricular assist device for acute myocardial infarction and cardiogenic shock. J Heart Lung Transplant, 26(7), 756-8.
    123. Warshauer DM, Archer RK, Selzman CH, Tmaddon HS, Mauro MA (2007). Aortic pseudoaneurysm from penetrating superior vena cava stent. Radiology, 234(3), 901-4.
    124. Warshauer DM, Archer RK, Selzman CH, Tamaddon HS, Mauro MA (2007). Case 115: aortic pseudoaneurysm from penetrating superior vena cava stent. Radiology, 243(3), 901-4. ()
    125. Selzman C (2007). Invited commentary. Ann Thorac Surg, 83(5), 1758-9. ()
    126. Selzman CH (2006). Invited commentary. Ann Thorac Surg, 82(4), 1418-9. ()
    127. Selzman CH, Bhati RS, Sheridan BC, Stansfield WE, Mill MR (2006). Surgical therapy for heart failure. J Am Coll Surg, 203(2), 226-39; quiz A59-60. ()
    128. Gray NA Jr, Selzman CH (2005). Current status of the total artificial heart. Am Heart J, 152(1), 4-10. ()
    129. Gray NA Jr, Selzman CH (2006). Current status of the total artificial heart. Am Heart J, 152(1), 4-10.
    130. Pathak A, Zhao R, Monroe DM, Roberts HR, Sheridan BC, Selzman CH, Stouffer GA (2006). Thrombin generation in vascular tissue. J Thromb Haemost, 4(1), 60-7. ()
    131. Bhati RS, Sheridan BC, Mill MR, Selzman CH (2005). Heart transplantation for progressive cardiomyopathy as a manifestation of MELAS syndrome. J Heart Lung Transplant, 24(12), 2286-9. ()
    132. Zimmerman MA, Reznikov LL, Raeburn CD, Selzman CH (2004). Interleukin-10 attenuates the response to vascular injury. J Surg Res, 121(2), 206-13. ()
    133. Selzman CH, Netea MG, Zimmerman MA, Weinberg A, Reznikov LL, Grover FL, Dinarello CA (2003). Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis. J Thorac Cardiovasc Surg, 126(3), 688-93. ()
    134. Zimmerman MA, Reznikov LL, Sorensen AC, Selzman CH (2003). Relative contribution of the TNF-alpha receptors to murine intimal hyperplasia. Am J Physiol Regul Integr Comp Physiol, 284(5), R1213-8. ()
    135. Zimmerman MA, Selzman CH, Cothren C, Sorensen AC, Raeburn CD, Harken AH (2003). Diagnostic implications of C-reactive protein. Arch Surg, 138(2), 220-4. ()
    136. Selzman CH, Zimmerman MA, Campbell DN (2003). ALCAPA in an adult with preserved left ventricular function. J Card Surg, 18(1), 25-8. ()
    137. Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, Banerjee A (2002). Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol, 283(4), H1455-61. ()
    138. Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken AH (2002). Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury. Am J Physiol Regul Integr Comp Physiol, 283(2), R505-12. ()
    139. Albright TN, Zimmerman MA, Selzman CH (2002). Vasopressin in the cardiac surgery intensive care unit. Am J Crit Care, 11(4), 326-30; quiz 331-2. ()
    140. Zimmerman MA, Selzman CH, Reznikov LL, Raeburn CD, Barsness K, McIntyre RC Jr, Hamiel CR, Harken AH (2002). Interleukin-11 attenuates human vascular smooth muscle cell proliferation. Am J Physiol Heart Circ Physiol, 283(1), H175-80. ()
    141. Zimmerman MA, Albright TN, Raeburn CD, Selzman CH (2002). Vasopressin in cardiovascular patients: therapeutic implications. Expert Opin Pharmacother, 3(5), 505-12. ()
    142. Selzman CH, Turner AS, Gaynor JS, Miller SA, Monnet E, Harken AH (2002). Inhibition of intimal hyperplasia using the selective estrogen receptor modulator raloxifene. Arch Surg, 137(3), 333-6. ()
    143. Zimmerman MA, Selzman CH, Raeburn CD, Calkins CM, Barsness K, Harken AH (2002). Clinical applications of cardiovascular angiogenesis. J Card Surg, 16(6), 490-7. ()
    144. Shames BD, McIntyre RC Jr, Bensard DD, Pulido EJ, Selzman CH, Reznikov LL, Harken AH, Meng X (2001). Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10. J Surg Res, 99(2), 187-93. ()
    145. Selzman CH, Miller SA, Harken AH (2001). Therapeutic implications of inflammation in atherosclerotic cardiovascular disease. Ann Thorac Surg, 71(6), 2066-74. ()
    146. Selzman CH (2001). Current approaches to therapy for vascular injury. Expert Opin Pharmacother, 2(5), 753-64. ()
    147. Selzman CH, Miller SA, Zimmerman MA, Harken AH (2001). The case for beta-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Arch Surg, 136(3), 286-90. ()
    148. Kim SH, Reznikov LL, Stuyt RJ, Selzman CH, Fantuzzi G, Hoshino T, Young HA, Dinarello CA (2001). Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain. J Immunol, 166(1), 148-54. ()
    149. Shames BD, Zallen GS, McIntyre RC Jr, Bensard DD, Pulido EJ, Miller SA, Pomerantz BJ, Selzman CH, Meng X, Harken AH (2000). Chemokines as mediators of diseases related to surgical conditions. Shock, 14(1), 1-7. ()
    150. Shames BD, Zallen GS, McIntryre RC Jr, Bensard DD, Pulido EJ, Miller SA, Pomerantz BJ, Selzman CH, Meng X, Harken AH (2000). Chemokines as mediators of diseases related to surgical conditions. Shock, 14(1), 1-7.
    151. Gaynor JS, Monnet E, Selzman C, Parker D, Kaufman L, Bryant HU, Mallinckrodt C, Wrigley R, Whitehill T, Turner AS (2000). The effect of raloxifene on coronary arteries in aged ovariectomized ewes. J Vet Pharmacol Ther, 23(3), 175-9. ()
    152. Miller SA, Selzman CH, Shames BD, Barton HA, Johnson SM, Harken AH (2000). Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation. J Surg Res, 90(1), 76-81. ()
    153. Netea MG, Selzman CH, Kullberg BJ, Galama JM, Weinberg A, Stalenhoef AF, Van der Meer JW, Dinarello CA (2000). Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol, 30(2), 541-9. ()
    154. Reznikov LL, Shames BD, Barton HA, Selzman CH, Fantuzzi G, Kim SH, Johnson SM, Dinarello CA (2000). Interleukin-1beta deficiency results in reduced NF-kappaB levels in pregnant mice. Am J Physiol Regul Integr Comp Physiol, 278(1), R263-70. ()
    155. Gaynor JS, Monnet E, Selzman C, Parker D, Kaufman L, Bryant HU, Mallinckrodt C, Wrigley R, Whitehill T, Turner AS (2000). The effect of raloxifene on coronary arteries in aged ovariectomized ewes. J Vet Pharmacol Ther, 23, 175-179.
    156. Raeburn CD, Cleveland JC, Selzman CH, Harken AH (2000). Ischemic preconditioning in myocardial revascularization with intermittent aortic cross-clamping. J Card Surg, 15, 339-340.
    157. Sheridan BC, Dinarello CA, Meldrum DR, Fullerton DA, Selzman CH, McIntyre RC Jr (1999). Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury. Am J Physiol, 277(5), L861-7. ()
    158. Cain BS, Meldrum DR, Meng X, Pulido EJ, Shames BD, Selzman CH, Banerjee A, Harken AH (1999). Exogenous calcium preconditions myocardium from patients taking oral sulfonylurea agents. J Surg Res, 86(2), 171-6. ()
    159. Pulido EJ, Shames BD, Selzman CH, Barton HA, Banerjee A, Bensard DD, McIntyre RC Jr (1999). Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation. Am J Physiol, 277(4), L769-76. ()
    160. Zimmerman MA, Selzman CH, Harken AH (1999). Surgical implications of therapeutic angiogenesis. Surgery (Oxf), 125(3), 243-9.
    161. Selzman CH, Shames BD, McIntyre RC Jr, Banerjee A, Harken AH (1999). The NFkappaB inhibitory peptide, IkappaBalpha, prevents human vascular smooth muscle proliferation. Ann Thorac Surg, 67(5), 1227-31; discussion 1231-2. ()
    162. Shames BD, Selzman CH, Pulido EJ, Meng X, Meldrum DR, McIntyre RC Jr, Harken AH, Banerjee A (1999). LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent. J Surg Res, 83(1), 69-74. ()
    163. Reznikov LL, Fantuzzi G, Selzman CH, Shames BD, Barton HA, Bell H, McGregor JA, Dinarello CA (1999). Utilization of endoscopic inoculation in a mouse model of intrauterine infection-induced preterm birth: role of interleukin 1beta. Biol Reprod, 60(5), 1231-8. ()
    164. Selzman CH, Shames BD, Reznikov LL, Miller SA, Meng X, Barton HA, Werman A, Harken AH, Dinarello CA, Banerjee A (1999). Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation. Circ Res, 84(8), 867-75. ()
    165. Zimmerman MA, Selzman CH, Harken AH (1999). Surgical implications of therapeutic angiogenesis. Surgery, 125(3), 243-9. ()
    166. Selzman CH, Gaynor JS, Turner AS, Whitehill TA, Horwitz LD, Harken AH (1998). Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta1. J Surg Res, 80(2), 380-5. ()
    167. Selzman CH, Meldrum DR, Cain BS, Meng X, Shames BD, Ao L, Harken AH (1998). Interleukin-10 inhibits postinjury tumor necrosis factor-mediated human vascular smooth muscle proliferation. J Surg Res, 80(2), 352-6. ()
    168. Shames BD, Selzman CH, Meldrum DR, Pulido EJ, Barton HA, Meng X, Harken AH, McIntyre RC Jr (1998). Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. Shock, 10(6), 389-94. ()
    169. Selzman CH, Gaynor JS, Turner AS, Johnson SM, Horwitz LD, Whitehill TA, Harken AH (1998). Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor. Circulation, 98(19), 2049-54. ()
    170. Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RC Jr, Harken AH (1998). Therapeutic implications of interleukin-10 in surgical disease. Shock, 10(5), 309-18. ()
    171. Selzman CH, Whitehill TA, Krupski WC (1998). Thrombophilia and activated protein C resistance. Ann Vasc Surg, 12(6), 601-4. ()
    172. Shames BD, Meldrum DR, Selzman CH, Pulido EJ, Cain BS, Banerjee A, Harken AH, Meng X (1998). Increased levels of myocardial IkappaB-alpha protein promote tolerance to endotoxin. Am J Physiol, 275(3), H1084-91. ()
    173. Selzman CH, Shames BD, Whitehill TA, Harken AH, McIntyre RC Jr (1998). Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferation. Surgery, 124(2), 318-26; discussion 326-7. ()
    174. Meng X, Ao L, Meldrum DR, Cain BS, Shames BD, Selzman CH, Banerjee A, Harken AH (1998). TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol, 275(2), R502-8. ()
    175. Krupski WC, Selzman CH, Floridia R, Strecker PK, Nehler MR, Whitehill TA (1998). Contemporary management of isolated iliac aneurysms. J Vasc Surg, 28(1), 1-11; discussion 11-3. ()
    176. Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RC Jr, Harken AH (1998). Therapeutic implications of interleukin-10 in surgical disease. Shock, 10(5), 309-18.
    177. Shames BD, Selzman CH, Meng X, Meldrum DR, Cain BS, Harken AH (1998). Genes don't count. Arch Surg, 133(6), 667-9.
    178. Shames BD, Selzman CH, Meng X, Meldrum DR, Cain BS, Harken AH (1998). Genes don't count. Arch Surg, 133(6), 667-9. ()
    179. Selzman CH, McIntyre RC Jr, Shames BD, Whitehill TA, Banerjee A, Harken AH (1998). Interleukin-10 inhibits human vascular smooth muscle proliferation. J Mol Cell Cardiol, 30(4), 889-96. ()
    180. Selzman CH, Whitehill TA, Shames BD, Pulido EJ, Cain BS, Harken AH (1998). The biology of estrogen-mediated repair of cardiovascular injury. Ann Thorac Surg, 65(3), 868-74. ()
    181. Cain BS, Meldrum DR, Selzman CH, Cleveland JC Jr, Meng X, Sheridan BC, Banerjee A, Harken AH (1997). Surgical implications of vascular endothelial physiology. Surgery, 122(3), 516-26. ()
    182. Selzman CH, Turner AS, Johnson SM, Cain BS, Harken AH, Whitehill TA (1997). Chronic estrogen replacement inhibits aortic intimal hyperplasia independent of serum lipids. J Card Surg, 12(4), 228-34. ()
    183. Meldrum DR, Cleveland JC Jr, Sheridan BC, Rowland RT, Selzman CH, Banerjee A, Harken AH (1997). Alpha-adrenergic activation of myocardial NF kappa B during hemorrhage. J Surg Res, 69(2), 268-76. ()
    184. Krupski WC, Selzman CH, Whitehill TA (1997). Unusual causes of mesenteric ischemia. Surg Clin North Am, 77(2), 471-502. ()

    Review

    1. DiChiacchio L, Goodwin ML, Kagawa H, Griffiths E, Nickel IC, Stehlik J, Selzman CH (2023). Heart Transplant and Donors After Circulatory Death: A Clinical-Preclinical Systematic Review. [Review]. J Surg Res, 292, 222-233. ()
    2. Kanwar MK, Selzman CH, Ton VK, Miera O, Cornwell WK 3rd, Antaki J, Drakos S, Shah P (2022). Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support. [Review]. J Heart Lung Transplant, 41(10), 1324-1334. ()
    3. Tsarova K, Morgan AE, Melendres-Groves L, Ibrahim MM, Ma CL, Pan IZ, Hatton ND, Beck EM, Ferrel MN, Selzman CH, Ingram D, Alamri AK, Ratcliffe MB, Wilson BD, Ryan JJ (2022). Imaging in Pulmonary Vascular Disease-Understanding Right Ventricle-Pulmonary Artery Coupling. [Review]. Compr Physiol, 12(4), 3705-3730. ()

    Book Chapter

    1. Stansfield WE, Koliopoulou A, Mckellar SH, Selzman CH (In Press, 2018). Mechanical Circulatory Support. In Taggart DP, Mohr FW (Eds.), Current Concepts in Cardiac Surgery. Bentham Books.

    Case Report

    1. Wilder TJ, Sharma V, Koliopoulou A, McKellar SH, Selzman CH, Glotzbach JP (2019). Rapid-deployment aortic valve replacement after aortic root replacement: A safe alternative to redo root replacement. J Card Surg, 35(1), 222-225. ()

    Editorial

    1. DiChiacchio L, Goodwin ML, Kagawa H, Selzman CH (2022). Commentary: Trainee or trainer? J Thorac Cardiovasc Surg, 166(3), 902-903. ()
    2. Selzman CH (2021). Commentary: Heart recovery: License to be offensive-on myocardial recovery following durable left ventricular assist device support. JTCVS Open, 8, 6-7. ()
    3. Goodwin ML, Kagawa H, Selzman CH (2021). The good, the bad, the ugly: Optimal left ventricular assist device duration in bridge to transplantation. JTCVS Open, 8, 116-120. ()
    4. Glotzbach JP, Selzman CH (2020). Commentary: Recalibrating the eyeball test. J Thorac Cardiovasc Surg, 161(6), 2106-2107. ()
    5. Goodwin ML, Selzman CH (2020). Take a load off: Unloading and reperfusion. J Thorac Cardiovasc Surg, 161(6), 2046-2050. ()
    6. Goodwin ML, Selzman CH (2021). Commentary: What the eye doesn't see and the mind doesn't know, doesn't exist. J Thorac Cardiovasc Surg, 164(6), 1931-1932. ()
    7. Selzman C (2021). Commentary: Latent hypertrophic obstructive cardiomyopathy-(Un)clear and present danger. J Thorac Cardiovasc Surg. ()
    8. Griffin CL, Sharma V, Sarfati MR, Smith BK, Kraiss LW, McKellar SH, Koliopoulou A, Brooke BS, Selzman CH, Glotzbach JP (2020). Aortic disease in the time of COVID-19 and repercussions on patient care at an academic aortic center. J Vasc Surg, 72(2), 408-413. ()
    9. Selzman CH (2012). Invited commentary on "Should patients age 60 and older be bridged to transplant using a contiuous flow left ventricular assist device". Ann Thorac Surg, 94(6), 2024.
    10. Selzman CH (2011). Invited commentary on "Aortic valve cyclic stretch causes increased remodeling activitiy and enhanced serotonin receptor responsiveness". Ann Thorac Surg, 92, 153-54.
    11. Selzman CH (2009). Invited commentary on "In-hospital outcomes of off-pump multi-vessel total arterial and conventional artery bypass grafting: single surgeon, single center experience". 88, 53.
    12. Selzman CH (2009). Invited commentary on "Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotection". Ann Thorac Surg, 87, 819.
    13. Selzman CH (2008). Invited commentary on "Gene Transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits. Ann Thorac Surg, 85, 585-6.
    14. Selzman CH (2006). NFkappaB decoys to prevent vein graft stenosis Invited Editorial on "inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model". J Mol Cell Cardiol, 41(3), 410-2. ()
    15. Selzman CH (2006). Invited commentary on "Improved mechanical reliability of the Heartmate XVE left ventricular assist device. Ann Thorac Surg, 82(4), 1418-1419.

    Letter

    1. Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, Wever-Pinzon O, Morshedzadeh JH, Dranow E, Selzman CH, Fang JC, Drakos SG (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. [Letter to the editor]. Circulation, 140(1), 98-100. ()

    Other

    1. Lee YS, Javan H, Reems JA, Li L, Lusty J, Schaaf CI, Pierce J, Phillips JD, Selzman CH (2022). Acellular human amniotic fluid protects the ischemic-reperfused rat myocardium. Am J Physiol Heart Circ Physiol (322(3), pp. H406-H416). United States. ()
    2. Atluri P, Silvestry SC, Teuteberg JJ, Milano CA, Selzman CH, Cowger JA (2022). What If the Destination Is Transplant? Outcomes of Destination Therapy Patients Who Were Transplanted. ASAIO J (68(2), pp. 178-183). United States. ()

  • News & Podcasts

    News

    Podcasts